b-lactams C-H activation · Discovery of novel β-lactam analogs oriented to control multidrug-resistant bacteria enabled by Pd-catalyzed C–H activation of aliphatic amines
Horizon 2020 — Marie Skłodowska-Curie Actions
- Duration
- 2015-05-01 → 2017-04-30
- EU contribution
- €183,455
- Participants
- 1
- Scheme
- MSCA-IF-EF-ST
Lines connect the coordinator with its partners.
Results in brief
Discovery of novel β-lactam analogs oriented to control multidrug-resistant bacteria enabled by Pd-catalyzed C–H activation of aliphatic amines
Methods that enable practical and selective functionalization of aliphatic systems are of significant importance to the continued advance of chemical synthesis. Over the last two decades, transition-metal catalysis has emerged as an effective means of C–H activation using polar functionalities such as heteroarenes, carboxylic acids, and amide derivatives to modulate the cyclometallation process. The natural evolution of the field is the use of native functional groups to direct such C-H activation process. Recently, palladium-catalyzed C–H functionalization of aliphatic amine derivatives has emerged as a potentially powerful tactic for the synthesis of complex variants of these important molecules. While the functionalization of methyl C-H bonds have been explored, a major challenge remains the selective functionalization of methylene bonds. The activation of this class of bonds, on account of them being more sterically demanding than their primary counterparts, presents difficulties to both metal insertion and reductive elimination steps. Moreover, the functionalization of methtylene C–H bonds can generate stereogenic carbon centers, potentially causing stereoselectivity issues. The main objective of this work is the development of a C-H activation approach to transform simple aliphatic amines into b-lactams. Conclusion: During the last two years, we have developed first highly regio- and diasteroselective palladium-catalyzed carbonylation of methylene bonds in secondary aliphatic amines to furnish poly substituted trans-β-lactam scaffolds. This new methodology enables to transform simple aliphatic amines into poly substituted b-lactams in one step. Given the broad tolerance of this reaction to useful functional groups, we believe that this C–H carbonylation process will be of significant interest to practitioners of synthesis and medicinal chemistry, specifically for accessing antibiotics.
Data: CORDIS, © European Union
Project objective
In Europe, infections caused by multidrug-resistant bacteria lead to more than 25,000 deaths and expenses of billions of euros per year. These numbers dramatically increase when the rest of the world is taken into consideration. Shockingly, the pace of production of new antibiotics to control such microorganisms is stagnating. Therefore, developing new synthetic tools that enable the synthesis of scaffolds with potential antibiotic properties is crucial. Metal catalysed C–H activation represents a versatile tool for building chemical complexity. It mostly relies on directing functional groups to functionalize C–H bonds. Recently, Professor Gaunt at the University of Cambridge has uncovered a new C–H activation mode that enables the conversion of hindered amines into β-lactams. The first aim of this project is to develop this new reactivity mode into a versatile transformation that is able to convert a variety of cyclic and acyclic amines into substituted β-lactam scaffolds. To accomplish this goal, a multi parallel platform based on mass spectrometry, relying either on standard high-throughput procedures or flow chemistry, will be implemented and used to screen a large number of conditions to expand the scope of this new pathway for β-lactams. The flow chemistry system for reaction evaluation will be design in collaboration with Professors Alexei Lapkin (Dept. Chemical Engineering and Biotechnology) and Steve Ley (Chemistry Dept.) from the University of Cambridge. The readily discovered new conditions for C–H activation will then be employed to synthesize a plethora of β-lactams and β-sultam analogs starting from simple secondary amines. Finally, in collaboration with Professor David Spring (Chemistry Dept. University of Cambridge), the bioactivity of the resulting scaffolds will be evaluated against multidrug-resistant bacteria.
Original text from CORDIS.
Participants
- THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE · CAMBRIDGECoordinatorUnited Kingdom
Links
- View on CORDIS
- DOI: 10.3030/655856
- http://www-gaunt.ch.cam.ac.uk/
- https://web.archive.org/web/20170407225215/http://www-gaunt.ch.cam.ac.uk/
Data: CORDIS, © European Union
